• Fatma Bozkurt, Ömer Çoşkun, Sevda Yeleç, Muhammed Bekçibaşı, Muhammet Asena, and İhsan Bağlı.
• Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Health Science,Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
• Turk J Med Sci. 2022 Feb 1; 52 (1): 112011-20.

BackgroundCOVID - 19 disease may be seen with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID - 19 who had no comorbid disease.MethodsThis retrospective designed study included 217 patients with Covid PCR positive in typically COVID - 19 clinic. The patients were classified into asymptomatic, nonsevere, and severe disease groups. The symptoms, laboratory results, hospital followups and intensive care records of the patients and the findings of new borns are presented.ResultsMost of the patients (78%) were in the third trimester of pregnancy, and 103 patients in the study group had severe disease. Fever in the non-severe group and respiratory distress in the severe group were the most common symptoms in the patients. The severe clinical manifestations were specifically observed in the third trimester patients. In the severe group, neutrophil, lactat dehydrogenase, ferritin, CK - MB, IL - 6, and hospital stay were statistically higher than those in other groups (p < 0.05). Increase in BUN and creatine were the most predictive parameters in intensive care admission. While the intensive care unit (ICU) requirement was higher in patients in the severe group, premature birth was observed more frequently in the severe group (p < 0.05) .

15 keywords...

hide…